Study Identifies FGF23 as an Early Biomarker for Diabetic Kidney Disease Risk Medha Baranwal28 Feb 2025 8:00 AM ISTChina: A recent prospective study has highlighted the role of fibroblast growth factor 23 (FGF23) as an early biomarker for predicting the onset of...
Tight Glycemic Control Linked to Lower Mortality Risk in Type 2 Diabetes: Study Finds Medha Baranwal11 Feb 2025 8:00 AM ISTChina: A new study published in Diabetes, Obesity and Metabolism has highlighted the significant role of tight glycemic control in reducing long-term...
How Genetic Factors Are Associated with Behavioral Side Effects of GLP-1 Weight Loss Medication: Study Reveals Dr. Bhumika Maikhuri27 Jan 2025 8:00 AM ISTGlucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise...
Gout and CKD Synergy Sharply Elevates Cardiovascular Risks and Mortality in Diabetes Patients: Study Reveals Medha Baranwal17 Jan 2025 8:30 AM ISTSouth Korea: A recent study published in Diabetes, Obesity and Metabolism has revealed the detrimental interplay between gout and chronic kidney...
Oral Anti-Hyperglycaemic Therapies Effective for Management of diabetes secondary to pancreatic condition: Study Dr Riya Dave13 Jan 2025 9:45 AM ISTOral anti-hyperglycaemic therapies improve the glycaemic control in type 3c diabetes individuals as a consequence of pancreatic diseases. A recent...
Intermittent Fasting Shows Promise for Weight loss and improved Metabolic Health in new research Medha Baranwal21 Dec 2024 9:00 AM ISTChina: A recent comprehensive umbrella review has emphasized the potential benefits of intermittent fasting (IF), particularly time-restricted eating...
Atrasentan Enhances Insulin Sensitivity in Type 2 Diabetes Patients with Chronic Kidney Disease: Study Reveals Medha Baranwal30 Nov 2024 9:00 AM ISTNetherlands: A recent study, published in Diabetes, Obesity and Metabolism has revealed that atrasentan, an endothelin receptor antagonist,...
Semaglutide Improves Sperm Quality and Testosterone Levels in Obese Men with Type 2 Diabetes and Hypogonadism: Study Medha Baranwal21 Nov 2024 8:45 AM ISTSlovenia: A recent study published in Diabetes, Obesity and Metabolism has revealed that semaglutide, a medication primarily used to treat type 2...
Combining SGLT2 Inhibitors and Pioglitazone May Reduce Risk of MASH in Type 2 Diabetes, Study Finds Medha Baranwal16 Nov 2024 8:15 AM ISTChina: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) and pioglitazone...
Transforming Diabetes Management: Continuous Ketone Monitoring Offers New Hope for DKA Prevention, Study Medha Baranwal13 Nov 2024 8:45 AM ISTAustralia: In a recent study published in Diabetes, Obesity and Metabolism, the researchers present an innovative device that has the potential to be...
Oral Semaglutide Improves liver steatosis and injury in Diabetes Patients with MASLD, suggests study Jacinthlyn Sylvia29 Oct 2024 8:45 AM ISTA recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients with metabolic...
Triple Therapy: GEMI + DAPA Enhances Glycemic Control for Type 2 Diabetics on Metformin, SOLUTION 2 study Medha Baranwal3 Oct 2024 8:00 AM ISTSouth Korea: Gemigliptin and dapagliflozin dual add-on therapy (GEMI+DAPA) along with metformin is safe, effective, and well-tolerated, particularly...
